Presentation TCT 2023 TCT 645: Changes in Plaque Lipid Content After 1 year Intensive Versus Standard Statin Therapy : CITRUS study (Serial near-infrared spectroscopy assessment of change in coronary atherosclerotic plaque) Presenter: Sanghoon Shin October 25, 2023
Presentation TCT 2023 TCT 635: Performance of Near-Infrared Spectroscopy-Intravascular Ultrasound and Optical Coherence Tomography for Coronary Artery Plaque Structural Stress Analysis: Validation Against Histology Presenter: Retesh Bajaj October 25, 2023
Presentation TCT 2023 TCT 617: Plaque Stabilization and Regression: Another Significant Benefit of DynamX Bioadaptor Presenter: Stefan Verheye October 25, 2023
Presentation TCT 2023 TCT 177: Impact of Pericoronary Adipose Tissue Attenuation on Periprocedural Myocardial Injury in Patients with Chronic Coronary Syndrome Presenter: Tetsuya Yamamoto October 25, 2023
Presentation TCT 2023 TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial Presenter: David del Val October 25, 2023
Presentation TCT 2023 TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis Presenter: Hamza Naveed October 25, 2023
Presentation TCT 2023 TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial Presenter: Michel Azizi October 25, 2023
Presentation TCT 2023 TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study Presenter: Victor Zeijen October 25, 2023
Presentation TCT 2023 TCT 207: Prediction of Six- and Twelve-Months Blood Pressure Results After Renal Denervation for Arterial Hypertension Presenter: Karl Fengler October 25, 2023
Presentation TCT 2023 TCT 152: Echocardiographic Findings Following Renal Sympathetic denervationfor treatment resistant hypertension, The ReShape CV-risk study. Presenter: Anna Subbotina October 25, 2023
Presentation TCT 2023 Market Expansion for Transcatheter Treatment of PE: Barriers and Potential Solutions Presenter: Andrew Sharp October 23, 2023
Presentation TCT 2023 The Thrombectomy Device Explosion: A Hospital/Health System’s Perspective Presenter: Dana Asato October 23, 2023
Presentation TCT 2023 Building the Clinical Evidence to Move The Field Forward: Current Challenges and Research Strategies Presenter: Peter Monteleone October 23, 2023
Presentation TCT 2023 The Total Product Lifecyle Advisory Program: A Closer Partnership with FDA Presenter: Kimberly Ferlin October 23, 2023
Presentation TCT 2023 Animal Studies of Cardiovascular Devices: The New CDRH Animal Study Guidance Document Presenter: Natalie Miller October 23, 2023
Presentation TCT 2023 Biocompatibility Assessment of Cardiovascular Devices: Just-in-Time Testing Presenter: Girish Kumar October 23, 2023
Presentation TCT 2023 Special Considerations in Conducting an Early Feasibility/First-in-Human Study in the US: From Bench to Bedside Presenter: Changfu Wu October 23, 2023